bromodeoxyuridine has been researched along with Leukemia P388 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, A; Ohyama, T; Osaki, K; Sakakibara, T; Sakakura, C; Sasaki, S; Shimotsuma, M; Shirasu, M; Takhashi, T; Tsujimoto, H | 1 |
| Balzarini, J; De Clercq, E; Keizer, HJ; Landuyt, W; Pauwels, R; van der Schueren, E | 1 |
| Bankert, R; Mayers, G; Preisler, HD; Raza, A; Spiridonidis, C; Ucar, K | 1 |
3 other study(ies) available for bromodeoxyuridine and Leukemia P388
| Article | Year |
|---|---|
Site-specific implantation in the milky spots of malignant cells in peritoneal dissemination: immunohistochemical observation in mice inoculated intraperitoneally with bromodeoxyuridine-labelled cells.
Topics: Animals; Bromodeoxyuridine; Female; Injections, Intraperitoneal; Leukemia P388; Lymphoid Tissue; Male; Melanoma, Experimental; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasm Invasiveness; Neoplasm Transplantation; Omentum; Organ Specificity; Peritoneal Neoplasms; Sensitivity and Specificity; Staining and Labeling | 1995 |
Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bromodeoxyuridine; Female; Fluorouracil; Lethal Dose 50; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA | 1988 |
Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; Cell Cycle; Cytarabine; DNA; Leukemia P388; Mice; Thymidine; Tritium | 1985 |